DR. JAN
QUISTGAARD

Liquidity Event Planning 22 Tim Howard, MBA Ms. Debra Bingham

IND Exemptions 24 Ms. Natasha Leskovsek

Gastroretentive Dosage Forms 26 Matthew D. Burke, PhD Prof. Clive G. Wilson

pH Monitoring & Gamma Scintigraphy 50 Ms. Erin Peters Ms. Ann Vickers

SCF Enabling Technologies 64 Pratibhash Chattopadhyay, PhD Boris Y. Shekunov, PhD

The science & business of specialty pharma, biotechnology, and drug delivery

Michel Ms. Cindy H. Mr. Jason
Afargan, PhD Dubin McKinnie
Ovveerrcomiingg tthhe ^The ^Worr^ll^d ^off The Fut^tur^re of^fAbssorrpttiion Liimiitt ^Hand-^-^He^e^l^l^d Tr^ransdermal^l_i_i_n _t_t_he _GI_I _Tr_r_a_a_c_c_t_tIInjjeccttiion Syyssttemss Delliivverry Reelliiess
on Acttiive Patch
Technollogy